UCB - Bénéfice Avant Impôts

Prix De L'Action
225.10
Variation Quotidienne
-2.60 -1.14%
Mensuellement
-11.17%
Annuel
39.68%
Q2 Prévisions
233.96




Bénéfice Avant Impôts Changement Date
Alcon AG USD 264M 19M 2025-12
Almirall EUR 30.32M 22M 2025-12
Amarin USD -852K 7.26M 2025-12
argenx SE USD 386.05M 99.15M 2025-09
AstraZeneca USD 3.24B 117M 2025-09
Bayer EUR -1.16B 735M 2025-09
Galapagos EUR -221.49M 117.07M 2025-09
Genmab DKK 55M 427M 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Merck EUR 1.29B 458.1M 2025-09
Novartis USD 4.64B 445M 2025-12
Orion EUR 113.4M 213.6M 2026-03
Recordati EUR 144.95M 25.46M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06